Understanding pelvic inflammatory disease. risk factors, symptoms, and long-term health implications

Nº de DOI: 10.34896/RSI.2025.24.71.001

AUTHORS

1. Santiago Napoleón Chata García. General Practitioner. Attached to the Alfredo Noboa Provincial Hospital. Independent Researcher of the Research and Teaching Department Matilde Hidalgo of Procel. Graduate of the University of Guayaquil. (Guaranda-Ecuador). https://orcid.org/0000-0002-9866-8118
2. Anggie Estefania Choez Baldeon. General Practitioner. Attached to the Flor of Bastión 2 Health Center. Graduate of the University of Guayaquil. (Guayaquil -Ecuador). https://orcid.org/0009-0009-9806-9850
3. Edisson Eduardo Moposita Sevilla. Medical Surgeon. Attached to Private Clinics of Ecuador. Graduated from the Autonomous Regional University of the Andes. (Ambato-Ecuador). https://orcid.org/0009-0008-8162-9789
4. Alvaro Daniel Caseres Ampudia. Medical Surgeon. Attached to the Panzaleo Health Center. Graduated from the Autonomous Regional University of the Andes. (Salcedo -Ecuador). https://orcid.org/0009-0008-1895-7034
5. Michelle Stefanny Navarrete Cisneros. Medical Surgeon. Attached to the Río Verde Health Post. Graduated from UTE University. (Quito -Ecuador). https://orcid.org/0009-0001-7802-7137

ABSTRACT

This paper aims to explore the intricate relationship between risk factors, symptoms, and the long-term health implications of Pelvic Inflammatory Disease, highlighting the necessity for enhanced public health strategies to combat this pervasive condition.

KEY WORDS

Pelvic inflammatory disease, risk factors, clinical presentation, long-term outcomes and complications.

RESUMEN

Este artículo tiene como objetivo explorar la intrincada relación entre los factores de riesgo, los síntomas y las implicaciones para la salud a largo plazo de la enfermedad inflamatoria pélvica, destacando la necesidad de mejorar las estrategias de salud pública para combatir esta afección generalizada.

PALABRAS CLAVE

Enfermedad inflamatoria pélvica, factores de riesgo, presentación clínica, resultados a largo plazo y complicaciones.

INTRODUCTION

Pelvic Inflammatory Disease (PID) is a significant public health concern that affects millions of women globally, often leading to severe reproductive and systemic health complications. Characterized by the inflammation of the female reproductive organs, PID is primarily caused by sexually transmitted infections, such as chlamydia and gonorrhea, but can also arise from non-sexually transmitted pathogens following surgical procedures or childbirth. The risk factors associated with PID are multifaceted, encompassing lifestyle choices such as smoking, unprotected sexual practices, and a history of STIs, as well as demographic variables including age, socio-economic status, and ethnicity, which may render certain groups more vulnerable. The symptoms of PID, which commonly include pelvic pain, fever, and abnormal vaginal discharge, can vary widely among individuals, complicating timely diagnosis and treatment. Diagnostic methods often involve a combination of clinical assessments, laboratory tests, and imaging techniques, underscoring the need for awareness and education regarding the disease. Beyond its immediate symptoms, PID poses significant long-term health implications, including infertility, chronic pelvic pain, and ectopic pregnancies, as well as potential impacts on overall health that are often overlooked. Preventive measures, such as regular screenings, safe sexual practices, and prompt treatment of infections, are crucial in reducing the incidence of PID and its long-term consequences.

OBJECTIVE

To explore the intricate relationship between risk factors, symptoms, and long-term health consequences of pelvic inflammatory disease, highlighting the need for improved public health strategies to combat this widespread condition.

METHODOLOGY

This scientific review aims to provide a comprehensive analysis of pelvic inflammatory disease (PID), focusing on its risk factors, clinical symptoms, and long-term health implications. A systematic literature search is conducted across databases such as PubMed, Scopus, and Web of Science to identify relevant peer-reviewed articles, clinical guidelines, systematic reviews, and meta-analyses. Keywords and phrases used in the search include “pelvic inflammatory disease”, “PID risk factors”, “clinical presentation of PID”, “long-term outcomes of PID” and “PID complications”. Articles published in the last 20 years are prioritized to reflect current knowledge and advancements in the field.

Inclusion criteria focus on studies that examine the etiology of PID, particularly its association with sexually transmitted infections (STIs) such as Chlamydia trachomatis and Neisseria gonorrhoeae, as well as non-STI-related causes. Research exploring demographic, behavioral, and socioeconomic risk factors contributing to PID is included to provide a multifaceted understanding of disease susceptibility. Additionally, articles detailing the clinical symptoms of PID, including pelvic pain, abnormal vaginal discharge, fever, and irregular menstrual bleeding, are reviewed to identify patterns and diagnostic challenges.

The review emphasizes long-term health implications of PID, such as infertility, chronic pelvic pain, ectopic pregnancy, and recurrent infections. Studies reporting on the prevalence, mechanisms, and psychosocial impact of these complications are integrated to highlight the broader health burden associated with the condition. Research addressing disparities in diagnosis and treatment, particularly in underserved populations, is also examined to understand barriers to care and their consequences.

Data from selected studies are categorized into thematic areas: risk factors, symptomatology, diagnostic challenges, and long-term complications. Quantitative data on the incidence and prevalence of PID and its outcomes are synthesized to identify trends and gaps in current knowledge.

Emerging strategies for early detection, prevention, and management of PID are also explored. Studies evaluating interventions such as STI screening programs, patient education, and the use of novel diagnostic tools are included to assess their impact on reducing disease incidence and improving outcomes. Research on innovative therapies, including advanced antibiotic regimens and minimally invasive surgical approaches, is reviewed to highlight progress in treatment.

RESULTS

Risk Factors of Pelvic Inflammatory Disease:

What are the primary causes of Pelvic Inflammatory Disease?

Pelvic Inflammatory Disease (PID) is predominantly caused by the ascent of bacteria through the female reproductive tract, often originating from sexually transmitted infections (STIs) such as gonorrhea and chlamydia^1,2. These infections account for the majority of PID cases, underlining the critical role of these pathogens in the disease’s pathogenesis³. The bacteria make their way from the vagina, moving upwards through the cervix and into the uterus, where they can further spread into the pelvic cavity³. This unhindered movement of bacteria is facilitated by the anatomical structure of the pelvic space, which lacks barriers to impede the organisms’ progression throughout the pelvic region³. Consequently, the presence of these bacteria not only increases the risk of developing PID but also emphasizes the need for routine testing for STIs, especially gonorrhea and chlamydia, as a preventive measure to mitigate the incidence of PID and its associated complications².

How do lifestyle choices impact the risk of developing Pelvic Inflammatory Disease?

Lifestyle choices play a significant role in influencing the risk of developing Pelvic Inflammatory Disease (PID), with several factors being statistically associated with an increased likelihood of contracting this condition⁴. One critical lifestyle choice is the practice of safe sex, which can significantly reduce the risk of PID. Safe sex practices, including the use of condoms, help prevent the transmission of sexually transmitted infections (STIs) that often lead to this disease⁵. Additionally, regular STI testing is a proactive measure that can protect reproductive health and lower the risk of PID by ensuring that infections are identified and treated promptly before they can ascend and cause damage⁵. Smoking is another lifestyle factor that has been linked to an increased risk of developing PID. Smoking may impair the immune system and disrupt the natural flora of the reproductive tract, thereby creating a more conducive environment for infections to ascend and cause PID⁶. Therefore, it is crucial for individuals to make informed lifestyle choices by practicing safe sex, undergoing regular STI testing, and avoiding smoking to mitigate the risk of PID. By addressing these modifiable risk factors, individuals can take significant steps toward safeguarding their reproductive health.

Which demographic groups are most at risk for Pelvic Inflammatory Disease?

Demographic factors play a crucial role in identifying groups most at risk for Pelvic Inflammatory Disease (PID), with age, race, and sexual history being significant determinants. Young women, particularly adolescents and young adults, are notably vulnerable due to higher rates of sexual activity and lower likelihood of practicing safe sex, which are established risk factors for PID⁷. In the United States, racial disparities are evident, as black women have nearly double the incidence of PID compared to their white counterparts, highlighting the need for targeted public health interventions to address these inequities⁸. Additionally, previous diagnoses of sexually transmitted infections (STIs) significantly elevate the risk of PID, with non-Hispanic black and white women reporting similar high prevalence rates, suggesting that STI history is a critical factor across racial lines⁹. Furthermore, despite a general decline in PID rates across most demographics between 1982 and 1988, white teenagers were an exception, indicating that interventions during adolescence could be particularly beneficial in mitigating PID risk. To effectively reduce the incidence of PID, public health strategies must focus on education and preventive measures tailored to the most at-risk groups, including safe sex practices, regular STI screenings, and addressing racial and socioeconomic disparities.

Symptoms of Pelvic Inflammatory Disease:

What are the common symptoms associated with Pelvic Inflammatory Disease?

Pelvic Inflammatory Disease (PID) is characterized by a range of symptoms that can vary in intensity and recognition. The most frequently reported symptom is pelvic pain, which can manifest in various forms, such as pain that is centralized or felt on either side of the pelvis³. This pain is often accompanied by discomfort in the lower abdomen, which is another prevalent symptom that can present as a tender, sore sensation or as a persistent dull ache^1,3. Additionally, many individuals with PID report experiencing pain during sexual intercourse, with the pain often described as deep within the pelvic area¹. This symptom not only impacts physical health but can also affect emotional well-being and intimate relationships. Furthermore, irregular vaginal discharge is a common symptom that can indicate the presence of PID, although it might be mild and easily overlooked^1,10. The complexity of these symptoms underscores the necessity for increased awareness and timely medical intervention, as they can often be subtle or entirely absent, leading to potential complications such as chronic pelvic pain or infertility if left untreated¹⁰.

How do symptoms of Pelvic Inflammatory Disease vary between individuals?

The symptoms of Pelvic Inflammatory Disease (PID) exhibit notable variability among individuals, complicating both diagnosis and treatment approaches. This variability is primarily rooted in the heterogenous nature of the disease’s presentation, where the severity and type of pelvic or lower abdominal pain differ significantly from one patient to another¹¹. Such disparities necessitate the use of broad diagnostic criteria that aim to encompass the full spectrum of possible symptom manifestations, ensuring that all potential cases are identified despite the diverse clinical presentations¹¹. For instance, during clinical examinations, signs such as tenderness of the cervix, adnexa, or uterus may be present in some individuals but absent in others, further highlighting the individualized nature of PID symptoms¹¹. This symptom diversity underscores the importance of personalized medical assessments and the need for healthcare practitioners to consider a wide range of clinical signs when diagnosing PID. As a result, developing more precise diagnostic tools and treatment plans tailored to individual symptom profiles is crucial for improving patient outcomes in PID management.

What diagnostic methods are used to identify symptoms of Pelvic Inflammatory Disease?

In diagnosing Pelvic Inflammatory Disease (PID), a purely clinical approach is utilized, focusing on the observation of lower genital tract inflammation and symptoms such as leukorrhea, as well as evaluating pelvic organ tenderness¹². Health care providers rely on a combination of clinical findings to diagnose PID, as there is no single test that can accurately identify the disease¹³. This method emphasizes the importance of maintaining a high index of suspicion, especially in women presenting with genital tract symptoms and a risk for sexually transmitted infections¹². While laparoscopy is a diagnostic tool, it is not recommended as a first-line method due to its invasive nature and cost implications¹². Instead, clinicians focus on signs of inflammation and tenderness, often making use of ultrasonography and cervical secretion analysis to support their clinical diagnosis¹⁴. This pragmatic approach ensures that women who are diagnosed with cervicitis or suspected acute PID receive timely antibiotic treatment, minimizing unnecessary antibiotic use in women who do not have PID and optimizing the diagnostic process to be both practical and cost-effective¹².

Long-term Health Implications of Pelvic Inflammatory Disease:

What are the potential long-term reproductive health effects of Pelvic Inflammatory Disease?

Pelvic Inflammatory Disease (PID) has significant implications for long-term reproductive health, primarily due to the potential for scarring and damage to the reproductive organs¹. One of the most critical outcomes of such damage is infertility, which occurs because PID may cause scarring in the fallopian tubes, obstructing the passage of ova and thereby preventing conception^1,15. Moreover, this scarring can result in ectopic pregnancies, where a fertilized egg implants outside the uterus, often in the fallopian tube, leading to severe complications, including life-threatening internal bleeding if untreated^1,15. Chronic pelvic pain is another debilitating consequence of PID, resulting from ongoing inflammation and tissue damage, which can significantly impact a woman’s quality of life^1,16. Therefore, early diagnosis and intervention are crucial to mitigate these long-term effects, emphasizing the need for comprehensive reproductive health strategies and prompt treatment for those diagnosed with PID¹.

How does Pelvic Inflammatory Disease impact overall health beyond reproductive issues?

Beyond its reproductive implications, Pelvic Inflammatory Disease (PID) significantly impacts overall health, including long-term complications such as infertility and chronic pelvic pain¹⁷. These complications can have profound effects on a woman’s quality of life, extending beyond the immediate physical discomfort associated with the infection¹⁷. Chronic pelvic pain, for instance, can lead to difficulties in daily functioning and contribute to mental health issues such as depression and anxiety. The persistent and pervasive nature of these symptoms underscores the importance of a comprehensive approach to managing PID, highlighting the need for timely and effective treatment to mitigate these broader health impacts¹⁷. Addressing PID in a holistic manner is crucial not only for preventing reproductive issues but also for ensuring the overall well-being of affected individuals, emphasizing the necessity for healthcare interventions that target both the physical and psychological dimensions of the disease.

What are the preventive measures to mitigate long-term health risks associated with Pelvic Inflammatory Disease?

To effectively mitigate the long-term health risks associated with Pelvic Inflammatory Disease (PID), a multifaceted approach involving personal and healthcare strategies is essential. One significant preventive measure is to avoid risk factors that contribute to infections, as these factors can lead to the development of PID¹⁸. Regular health check-ups play a critical role in early detection and prevention, allowing healthcare providers to identify and address potential issues before they escalate into more severe complications¹⁸. Moreover, the practice of good hygiene and staying informed about safe sexual practices are foundational in reducing the incidence of both PID and sexually transmitted infections, thereby safeguarding women’s reproductive health¹⁸. Health care providers should also focus on primary prevention through patient education and counseling, which empowers women to recognize early symptoms and take timely action to prevent adverse outcomes¹⁹. Overall, a combination of these preventive measures, alongside public health initiatives like comprehensive sexually transmitted disease control strategies, is vital in reducing the occurrence and impact of PID, thereby maintaining women’s reproductive health and preventing potential complications such as infertility and ectopic pregnancy¹⁹.

DISCUSSION

The findings of this research underscore the multifaceted nature of Pelvic Inflammatory Disease (PID), revealing not only its etiological links to sexually transmitted infections (STIs) but also the significant impact of demographic and lifestyle factors on its prevalence. The association of PID with STIs, particularly gonorrhea and chlamydia, emphasizes the critical need for routine screening and preventive education to mitigate risks, especially among high-risk populations such as young and black women. This demographic insight aligns with existing literature that suggests targeted interventions could be beneficial in reducing incidence rates. Furthermore, the variability in PID symptoms complicates diagnosis and highlights the necessity for clinicians to adopt a comprehensive approach to assessment, given that no singular test can definitively diagnose PID. The long-term health implications outlined in this study, including infertility, ectopic pregnancies, and chronic pelvic pain, necessitate urgent attention from both healthcare providers and public health officials to implement effective preventive strategies. Additionally, the psychological ramifications of PID, such as depression and anxiety, reveal an often-overlooked dimension of women’s health that warrants more research focus. Limitations of this study include a reliance on existing literature for certain risk factor correlations, which may not capture the full spectrum of individual experiences with PID. Future research should aim to investigate the psychosocial aspects of living with PID and develop tailored educational programs that address both physical and mental health. In conclusion, a multifaceted approach that emphasizes education, regular health check-ups, and awareness of safe sexual practices is essential in addressing the burden of PID, ultimately enhancing women’s reproductive health outcomes and quality of life.

CONCLUSIONS

1. Pelvic inflammatory disease (PID) remains a significant public health concern, with far-reaching implications for women’s reproductive health and overall well-being. This review highlights the multifaceted nature of PID, emphasizing the interplay of behavioral, socioeconomic, and biological factors in determining risk. The association between PID and sexually transmitted infections (STIs), particularly Chlamydia trachomatis and Neisseria gonorrhoeae, underscores the critical importance of STI prevention and early intervention in mitigating disease incidence. Non-STI-related etiologies further broaden the spectrum of PID risk, necessitating a comprehensive approach to risk assessment and patient education.
2. The clinical presentation of PID is highly variable, ranging from asymptomatic cases to severe symptoms such as pelvic pain, fever, and abnormal vaginal discharge. This variability contributes to diagnostic challenges, often leading to delays in treatment and an increased risk of complications. The review identifies a pressing need for improved diagnostic tools, including biomarker development and imaging technologies, to facilitate early and accurate identification of PID.
3. Long-term health implications of PID, including infertility, ectopic pregnancy, and chronic pelvic pain, significantly impact the quality of life for affected individuals. These outcomes not only highlight the need for timely and effective treatment but also underscore the importance of preventive measures such as regular STI screenings, public health education, and vaccination programs where applicable. Disparities in access to care, particularly among underserved populations, exacerbate the burden of PID and require targeted interventions to ensure equitable health outcomes.
4. Advances in antibiotic regimens and minimally invasive surgical techniques have improved the management of PID, yet challenges remain in addressing recurrent infections and the psychosocial consequences of the disease. Emerging research on preventive strategies, including the role of partner treatment and comprehensive sexual health education, offers hope for reducing the incidence and recurrence of PID.

REFERENCES

1. Cleveland Clinic. Pelvic Inflammatory Disease: Causes, Symptoms & Treatments [Internet]. Cleveland Clinic. 2023 [cited 2024 Nov 13]. Available from: https://my.clevelandclinic.org/health/diseases/9129-pelvic-inflammatory-disease-pid
2. Ross J, Guaschino S, Cusini M, Jensen J. 2017 European guideline for the management of pelvic inflammatory disease. International Journal of STD & AIDS [Internet]. 2017 Dec 4 [cited 2020 Apr 7];29(2):108–14. Available from: https://www.iusti.org/regions/europe/pdf/2017/IUSTIPIDGuideline2017.pdf
3. Kliman L. Pelvic Inflammatory Disease (PID): Symptoms & Causes [Internet]. Dr. Len Kliman. 2023 [cited 2024 Nov 13]. Available from: https://drlenkliman.com.au/articles/pelvic-inflammatory-disease-pid-symptoms-causes/
4. MedlinePlus. Pelvic Inflammatory Disease [Internet]. Medlineplus.gov. National Library of Medicine; 2018 [cited 2024 Nov 13]. Available from: https://medlineplus.gov/pelvicinflammatorydisease.html
5. Jennings LK, Krywko DM. Pelvic inflammatory disease [Internet]. National Library of Medicine. StatPearls Publishing; 2023 [cited 2024 Nov 13]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499959/
6. Hu P, Zhang S, Li H, Yan X, Zhang X, Zhang Q. Association between dietary trace minerals and pelvic inflammatory disease: data from the 2015–2018 National Health and Nutrition Examination Surveys. Frontiers in Nutrition [Internet]. 2023 Nov 27 [cited 2024 Nov 13];10(1). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10715429/#:~:text=Diets%20enriched%20with%20antioxidants%20(fruit
7. Greydanus DE, Bacopoulou F. Acute pelvic inflammatory disease. Pediatric Medicine [Internet]. 2019 Jul [cited 2024 Nov 13];2(1):36–6. Available from: https://pm.amegroups.org/article/view/4950/html
8. Eschenbach DA. Epidemiology of Pelvic Inflammatory Disease. Pelvic Inflammatory Disease [Internet]. 1997 [cited 2024 Nov 13];1(1):1–20. Available from: https://link.springer.com/chapter/10.1007/978-1-4612-0671-2_1
9. Kreisel K, Torrone E, Bernstein K, Hong J, Gorwitz R. Prevalence of Pelvic Inflammatory Disease in Sexually Experienced Women of Reproductive Age – United States, 2013-2014. MMWR Morbidity and mortality weekly report [Internet]. 2017 Jan 27 [cited 2024 Nov 13];66(3):80–3. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28125569
10. Mayo Clinic. Pelvic inflammatory disease (PID) – Symptoms and causes [Internet]. Mayo Clinic. 2022 [cited 2024 Nov 13]. Available from: https://www.mayoclinic.org/diseases-conditions/pelvic-inflammatory-disease/symptoms-causes/syc-20352594
11. Mitchell CM, Anyalechi GE, Cohen CR, Haggerty CL, Manhart LE, Hillier SL. Etiology and diagnosis of pelvic inflammatory disease: Looking beyond gonorrhea and chlamydia. The Journal of Infectious Diseases [Internet]. 2021 Aug 15 [cited 2024 Nov 13];224(2):S29–35. Available from: https://academic.oup.com/jid/article-abstract/224/Supplement_2/S29/6352159
12. Jaiyeoba O, Soper DE. A Practical Approach to the Diagnosis of Pelvic Inflammatory Disease. Infectious Diseases in Obstetrics and Gynecology [Internet]. 2011 [cited 2024 Nov 13];2011(1):1–6. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3148590/
13. Mayo Clinic. Pelvic inflammatory disease (PID) – Diagnosis and treatment – Mayo Clinic [Internet]. Mayoclinic.org. 2018 [cited 2024 Nov 13]. Available from: https://www.mayoclinic.org/diseases-conditions/pelvic-inflammatory-disease/diagnosis-treatment/drc-20352600
14. Goje O. Pelvic Inflammatory Disease (PID) [Internet]. MSD Manual Consumer Version. MSD Manuals; 2023 [cited 2024 Nov 13]. Available from: https://www.msdmanuals.com/home/women-s-health-issues/vaginitis-cervicitis-and-pelvic-inflammatory-disease/pelvic-inflammatory-disease-pid
15. Cunningham K. PID (Pelvic Inflammatory Disease): Causes, Longterm Effects, Treatment and Prevention: Kirstie Cunningham, MD, FACOG, NCMP: OB-GYN [Internet]. Metrohealthandwellness.com. 2025 [cited 2024 Nov 13]. Available from: https://www.metrohealthandwellness.com/blog/pid-pelvic-inflammatory-disease-causes-treatment-and-prevention
16. Trent M, Das B, Ronda J. Pelvic inflammatory disease: improving awareness, prevention, and treatment. Infection and Drug Resistance [Internet]. 2016 Aug [cited 2025 Jan 13]; Volume 9(1):191–7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998032/
17. Max Health Care. Pelvic Inflammatory Disease (PID) Treatment in Delhi, India [Internet]. Maxhealthcare.in. 2021 [cited 2024 Nov 13]. Available from: https://www.maxhealthcare.in/our-specialities/obstetrics-and-gynaecology/conditions-treatments/pelvic-inflammatory-disease
18. Washington AE, Cates W, Wasserheit JN. Preventing pelvic inflammatory disease. JAMA [Internet]. 1991 Nov 13 [cited 2024 Nov 13];266(18):2574–80. Available from: https://pubmed.ncbi.nlm.nih.gov/1942403/
19. American College of Obstetricians and Gynecologists. Pelvic Inflammatory Disease (PID) [Internet]. www.acog.org. 2019. Available from: https://www.acog.org/womens-health/faqs/pelvic-inflammatory-disease